UniProt/SwissProt ID: | HNRPQ_HUMAN |
Description: | synaptotagmin binding, cytoplasmic RNA interacting protein [Source:HGNC Symbol;Acc:16918] |
Location: | chr6 q14.3 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S509 | RGAAPsRGRGA | PhosphoSitePlus | |
Y472 | YDYYGyDYHNY | PhosphoSitePlus | |
Y434 | DDYYYyGPPHM | PhosphoSitePlus | |
S249 | RLFVGsIPKSK | RRM_1 | PhosphoSitePlus |
S249 | RLFVGsIPKSK | HPRD | |
Y373 | KKLKDyAFIHF | FGFR1 | phosphoELM; RegPhos |
T580 | SKRRQtNNQNW | PhosphoSitePlus | |
Y432 | MYDDYyYYGPP | PhosphoSitePlus | |
S115 | TKVADsSKGPD | PhosphoSitePlus | |
Y144 | TGQRKyGGPPP | PhosphoSitePlus | |
Y570 | RKADGyNQPDS | PhosphoSitePlus | |
S524 | GRAGYsQRGGP | PhosphoSitePlus | |
Y373 | KKLKDyAFIHF | RRM_1 | PhosphoSitePlus |
S531 | RGGPGsARGVR | PhosphoSitePlus | |
Y614 | ENQEFyQDTFG | PhosphoSitePlus | |
S575 | YNQPDsKRRQT | PhosphoSitePlus | |
S587 | NQNWGsQPIAQ | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
Y474 | YYGYDyHNYRG | PhosphoSitePlus | |
Y485 | GYEDPyYGYED | PhosphoSitePlus | |
S116 | KVADSsKGPDE | PhosphoSitePlus | |
Y373 | KKLKDyAFIHF | RegPhos | |
Y431 | QMYDDyYYYGP | PhosphoSitePlus | |
T110 | REKQGtKVADS | PhosphoSitePlus | |
Dephosphorylation site |
HNRPQ_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000358635 | R533K | COSMIC | Skin Cancer | 21984974 |
ENSP00000358635 | E183Q | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000347380 | E183Q | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000358635 | I326M | COSMIC | Skin Cancer | 21984974 |
ENSP00000358635 | Y469C | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000358635 | E397K | COSMIC | Head and Neck Cancer | 21798893 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000358635 | Hepatocellular Carcinoma | Normal vs. Cancer | cell line | Down | 0.33 | 18646787 |
ENSP00000358635 | hepatitis B virus | Normal vs. Cancer | tissue | Down | 0.3 | 14726492 |
ENSP00000358635 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Up | 17655343 | |
ENSP00000358635 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Up | 17655343 | |
ENSP00000358635 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Up | 6 | 17655343 |
ENSP00000358635 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Up | 17655343 | |
Hyperphosphorylation site |
HNRPQ_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
ZAGL2_HUMAN | HNRPQ_HUMAN | kinase -> substrate | RegPhos |
FGFR1_HUMAN | HNRPQ_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
HNRPQ_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0000398 | mRNA splicing, via spliceosome | IC | biological_process |
GO:0008143 | poly(A) RNA binding | IEA | molecular_function |
GO:0005634 | nucleus | TAS | cellular_component |
GO:0070937 | CRD-mediated mRNA stability complex | IDA | cellular_component |
GO:0070934 | CRD-mediated mRNA stabilization | IMP | biological_process |
GO:0071346 | cellular response to interferon-gamma | IDA | biological_process |
GO:0006396 | RNA processing | TAS | biological_process |
GO:0071204 | histone pre-mRNA 3'end processing complex | IEA | cellular_component |
GO:0000166 | nucleotide binding | IEA | molecular_function |
GO:0005654 | nucleoplasm | IEA | cellular_component |
GO:0003676 | nucleic acid binding | IEA | molecular_function |
GO:0003723 | RNA binding | TAS | molecular_function |
GO:0019048 | virus-host interaction | IEA | biological_process |
GO:0005783 | endoplasmic reticulum | IEA | cellular_component |
GO:0030529 | ribonucleoprotein complex | IDA | cellular_component |
GO:0071013 | catalytic step 2 spliceosome | IDA | cellular_component |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0017148 | negative regulation of translation | IMP | biological_process |
GO:0008380 | RNA splicing | TAS | biological_process |
GO:0005737 | cytoplasm | IEA | cellular_component |